The DOI matches its Crossref record.
GHb Is a Better Predictor of Cardiovascular Disease Than Fasting or Postchallenge Plasma Glucose in Women Without Diabetes: The Rancho Bernardo Study
Abstract
OBJECTIVE: To examine the relation between GHb, fasting plasma glucose (FPG), postchallenge plasma glucose (PCPG), and mortality from cardiovascular disease (CVD) and ischemic heart disease (IHD) in older adults. RESEARCH DESIGN AND METHODS: A community-based study of 1,239 nondiabetic older adults followed for an average of 8 years, from baseline (1984–1987) to 1993. RESULTS: GHb, but not FPG or PCPG, was significantly related to CVD and IHD mortality in women but not men. The age-adjusted relative hazard for those in the highest quintile of GHb (≥ 6.7%) compared with women with lower levels was 2.37 for fatal CVD (95% CI = 1.30−4.31, P = 0.005) and 2.43 for IHD (95% CI = 1.12−5.25, P = 0.024). This association persisted after adjustment for all covariates (age, systolic blood pressure, BMI, LDL, HDL, triglycerides, cigarette smoking, antihypertensive medication use, and estrogen use). GHb was significantly associated with LDL and HDL levels in women, but the association between GHb and CVD or IHD persisted after adjustment for these lipoproteins. CONCLUSIONS: We concluded that GHb is a better predictor of CVD and IHD mortality than FPG or PCPG in women without diabetes; no single measure of glycemia was predictive in men. The reason for the sex difference is unexplained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is important to note that even modest elevations in these biomarkers are associated with adverse outcomes, even when they do not meet accepted thresholds for clinical intervention.21,22”
From Socio‐economic differentials in peripheral biology: Cumulative allostatic load (2010) · cites this paper as [21]
Citations
Cited by
Sorted by citations
Items 101–161 of 161
Cohen, B. E., Barrett-Connor, E. L., Wassel, C. L., & Kanaya, A. M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.07.006 · Cited by 15
“Our results expand upon prior work showing that GHb predicts CHD events and mortality at levels lower than those currently considered to be diagnostic of impaired glucose tolerance or diabetes [3,8,13].”
BackgroundMethodResultSelf-citationSuccurro, E., Marini, M. A., Grembiale, A., Lugarà, M., Andreozzi, F., Sciacqua, A., Hribal, M. L., Lauro, R., Perticone, F., & Sesti, G. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.951 · Cited by 14
HbA1c levels in non‐diabetic Dutch children aged 8–9 years: the PIAMA birth cohort study
Jansen, H., Wijga, A. H., Smit, H. A., Scholtens, S., Kerkhof, M., Koppelman, G. H., de Jongste, J. C., & Stolk, R. P. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02641.x · Cited by 14
Kharazmkia, A., Ahmadpoor, P., Ziaei, S., Salamzadeh, J., Pour-Reza-Gholi, F., Khoshdel, A., Samavat, S., Samadian, F., & Nafar, M. (2014) · Iranian Journal of Kidney Diseases · Cited by 14
The Association Between Low Fasting Blood Glucose Value and Mortality
Wändell, P. E., & Theobald, H. (2007) · Current Diabetes Reviews · doi:10.2174/1573399810703040274 · Cited by 14
MEALTIME GLUCOSE REGULATION IN TYPE 2 DIABETES
Tuomilehto, J., & Prato, S. D. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11068.x · Cited by 13
Shultis, W. A., Leary, S. D., Ness, A., Scott, J., Martin, R. M., Whincup, P. H., Smith, G. D., & the ALSPAC Study Team (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01990.x · Cited by 12
Simons, L. A., Simons, J., Friedlander, Y., & McCallum, J. C. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.030 · Cited by 12
Ajudani, R., Zavareh, M. S. R., Karimi‐Sari, H., Safiabadi, M., Dolatimehr, F., Okhovatian, M., Ramezani‐Binabaj, M., & Pishgoo, B. (2017) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2017.1306309 · Cited by 12
“for the sex difference were not discussed [10].”
BackgroundThompson, W. G. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.11.1137 · Cited by 11
van Zuylen, M. L., van Wilpe, R., ten Hoope, W., et al. (2022) · Gerontology · doi:10.1159/000524886 · Cited by 10
Dheir, H., Özkahya, M., Kırçelli, F., Demirci, M. S., Aşçı, G., Töz, H., Ertilav, M., Köse, T., & Ok, E. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.8350 · Cited by 10
Kim, J.-H., Choi, S.-R., Lee, J.-R., Shin, J.-H., Lee, S.-J., Han, M.-A., Park, J., Bae, H. Y., & Kim, S. Y. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.5.435 · Cited by 10
Shin, J. H., Kang, J. I., Jung, Y. J., Choi, Y. M., Park, H. J., So, J. H., Kim, J. H., Kim, S. Y., & Bae, H. Y. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.2.103 · Cited by 9
Brunner, E. J., Shipley, M. J., Marmot, M. G., Mika Kivimaki, B., & Witte, D. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02921.x · Cited by 9
Reddigan, J. I., Ardern, C. I., Riddell, M. C., & Kuk, J. L. (2010) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000106 · Cited by 8
Lee, C. H., Chang, W. J., Chung, H. H., Kim, H. J., Park, S. H., Moon, J. S., Lee, J. E., Yoon, J. S., Chun, K. A., Won, K. C., et al. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.4.306 · Cited by 8
Self-citationMollet, J. J., Molist‐Brunet, N., Franch‐Nadal, J., Griera, J. M., Gramunt, I. O., & Barro, P. P. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)70838-0 · Cited by 10
“5,08 a 5,51 (+1 a +2 DE) 10 (10) 18 (17) 16 (15) 61 (58)”
Kim, J.-J., Kang, J., Goo, J.-J., Kim, K.-N., Lee, J., Kim, M.-K., & Kim, T. I. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.1.58 · Cited by 7
Serrano‐Ríos, M., Goday, A., & Larrad, T. M. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199903/04)15:2 · Cited by 40
Study Of HbA1c As A Reliable Indicator For Metabolic Syndrome In Non Diabetic Patients
Šutković, J., & Abdic-Nekic, V. (2013) · Southeast Europe Journal of Soft Computing · doi:10.21533/scjournal.v2i1.41 · Cited by 6
“Recent work suggests the utility of HbA1c as the predictor of future risk for diabetes mellitus in diverse ethnic groups [6,7,8].”
BackgroundAmidu, N., Owiredu, W. K. B. A., Quaye, L., Dapare, P. P. M., & Adams, Y. (2019) · International Journal of Chronic Diseases · doi:10.1155/2019/2578171 · Cited by 5
The association between glycated hemoglobin levels and mortality in non-diabetic elderly subjects
Grossman, A., Beloosesky, Y., Schlesinger, A., Gafter‐Gvili, A., Koren‐Morag, N., Meyerovitch, J., & Weiss, A. T. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.10.010 · Cited by 6
Yang, Y. A. N. G., Ling, S. U. N., ZHANG, H., HUANG, S., & Xiao, Z. H. U. (2018) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2018.01475 · Cited by 5
Memon, A. G., & Soomro, M. K. (2016) · Journal of Cardiovascular Diseases & Diagnosis · doi:10.4172/2329-9517.1000243 · Cited by 4
“Other authors reported alike outcomes, though inconsistently [20,21].”
ResultMostafa, S. A., Khunti, K., Srinivasan, B. T., Webb, D. R., & Davies, M. J. (2011) · Diabetes Management · doi:10.2217/dmt.10.11 · Cited by 4
Madhu, M., & Patni, A. (2023) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_46_22 · Cited by 4
“Studies have concluded that a progressive relation between glucose concentrations and cardiovascular disease extends below the current threshold used to define diabetes mellitus.[8,9] Therefore, patients without diabetes with suboptimal HbA1c levels may have a level of dysglycemia that may not meet the criteria for a…”
BackgroundNah, E. H., & Cho, H.-I. (2011) · Laboratory Medicine Online · doi:10.3343/lmo.2011.1.1.2 · Cited by 4
“한편 당화혈색소와 심혈관계질환의 연관성에 대해서 는 상이한 결과들이 보고되고 있다[7-10].”
Clinical applications of glycosylated haemoglobin
Reddy, S. A., Sachan, A., SrinivasaRao, P. V. L. N., & Mohan, A. (2013) · The Journal of Clinical and Scientific Research · doi:10.15380/2277-5706.jcsr.12.068 · Cited by 3
Strategies to prevent ischemic heart disease after kidney transplantation
Kasiske, B. L., & Israni, A. K. (2006) · Transplantation Reviews · doi:10.1016/j.trre.2006.02.001 · Cited by 3
Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients
Haider, D. G., Fuhrmann, H., Kovařík, J., Heiss, S., Graf, H., Auinger, M., Mittermayer, F., Wolzt, M., & Hörl, W. H. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02012.x · Cited by 3
Association of cardiovascular events with glycosylated haemoglobin in diabetic patients
Deo, R., Karki, P., Sharma, S., & Acharya, P. (1970) · Kathmandu University Medical Journal · doi:10.3126/kumj.v6i4.1739 · Cited by 3
Yoshida, Y., Chen, Z., Baudier, R. L., Krousel-Wood, M. A., Anderson, A. H., Fonseca, V. A., & Mauvais‐Jarvis, F. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13358 · Cited by 3
Glycated Haemoglobin: A Predictor of Vascular Risk?
Rizos, E. C., & Mikhailidis, D. P. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497534 · Cited by 2
Karjalainen, A. H. (2003) · Cited by 2
Bozzo, R., Rey, R., Manente, D., Zeballos, C., Rostan, M. G., Vitagliano, L., Calabria, F., & Mollerach, J. (2022) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.11.007 · Cited by 2
Reducing cardiovascular risk factors in patients with prediabetes
Chiasson, J., & Bernard, S. (2011) · Diabetes Management · doi:10.2217/dmt.11.28 · Cited by 2
Cardiovascular Complications after Renal Transplantation
Kasiske, B. L., & Israni, A. K. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3343-1.50032-3 · Cited by 2
Moore, B. F., Clark, M. L., Bachand, A. M., Reynolds, S. J., Nelson, T. L., & Peel, J. L. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw261 · Cited by 2
Variabilità biologica dell’emoglobina glicata: un’analisi sistematica della letteratura
Braga, F., Dolci, A., Mosca, A., et al. (2009) · Cited by 1
KASEM, M. S. E. S. S. M. S., & EL-BARBARY, M. D. W. A. H. Y. H. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.55142 · Cited by 1
Raj, M., Manu Reddy., S., Kiruthika, K., & Raju, R. (2020) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/5604307 · Cited by 1
Raj, M., Manu Reddy., S., Kiruthika, K., & Raju, R. (2020) · Indian Journal Of Applied Research · doi:10.36106/ijar/5707707 · Cited by 1
Bozzo, R., Rey, R., Manente, D., Zeballos, C., Rostan, M. G., Vitagliano, L., Calabria, F., & Mollerach, J. (2022) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2022.05.003 · Cited by 1
Ryu, Y., Park, Y., & Ye, B. J. (2015) · Daehan imsang geon-gang jeungjin hakoeji/Daehan imsang geon'gang jeungjin haghoeji · doi:10.15384/kjhp.2015.15.2.47 · Cited by 1
Relationship Between Plaque Echogenicity and Atherosclerosis Biomarkers
Kakisis, J. D., Avgerinos, E. D., Kadoglou, N. P. E., Sfyroeras, G. S., Moulakakis, K. G., & Liapis, C. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7425-8_20 · Cited by 1
“Apart from its common use as an indicator of intermediate-term glycemic control, HbA1c can also be used as a marker of increased mortality and cardiovascular disease in both diabetic and nondiabetic persons [31–36].”
BackgroundRECENT TRENDS IN THE MANAGEMENT OF PERIPHERAL VASCULAR DISEASE IN HIGH RISK PATIENTS
Sultan, S. A. H. (2007) · Cited by 1
An Optimal Cut Point of Hemoglobin A1c for Diagnosing Metabolic Syndrome in Japanese
Oda, E., & Kawai, R. (2009) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock2005.23.6_21 · Cited by 1
Behan, K. J., & Amin, R. (2004) · Laboratory Medicine · doi:10.1309/fyp50bgvpvlj9yk4
Diagnosi di diabete: è sufficiente l'HbA1c?
Cosma, C. (2013) · Padua Research Archive (University of Padova)
Johnson, A. J. (2016) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
(2019) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/vol5/3/6
Role of HbA1C as an Indicator of Insulin Resistance in Non-Diabetic Syndrome X Patients of Rajasthan
Vyas, D. R., Vyas, R. K., & Soni, Y. (2020) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2020.v06i01.018
“Recent work suggests the utility of HbA1c as the predictor of future risk for diabetes mellitus in diverse ethnic groups [10-12].”
BackgroundAltalhi, H. (2019) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2019.12.555840
Altalhi, K. G. H. (2019) · Significances of Bioengineering & Biosciences · doi:10.31031/sbb.2019.03.000573
Chaudhury, A. G. (2020) · International Journal of Clinical Case Reports and Reviews · doi:10.31579/2690-4861/081
(2019) · ARC Journal of Nutrition and Growth · doi:10.20431/2455-2550.0502003
“Similar result are reported by Park and colleagues among non diabetic women (Park et al. 1996).”
ResultPark, M., Lee, G. S., Kim, S., & Yun, M.-E. (2022) · The Korean Journal of Community Living Science · doi:10.7856/kjcls.2022.33.2.237
Abdalgbar, A., & Altalhi, H. (2019) · Cross Current International Journal of Medical and Biosciences · doi:10.36344/ccijmb.2019.v01i06.005
Alyasiri, H. M. F. (2015) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v5i3.138
Metadata
- Authors
- Park, S., Barrett-Connor, E., Wingard, D. L., Shan, J., & Edelstein, S.
- Affiliations
- University of California San Diego (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1996-05-01
- Volume
- 19
- Issue
- 5
- Pages
- 450-456
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2006867892
- Cited by
- 161
- References
- 0
- Citations by year
- 2023: 3 · 2022: 6 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 7 · 2014: 7 · 2013: 9 · 2012: 9
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 07491, T35HL007491)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK031801, DK-31801)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- HbA1c, cardiovascular mortality, ischemic heart disease mortality, fasting blood glucose, glycemic markers, sex differences, older women, cardiovascular risk prediction
- MeSH terms
- Adult, Age Factors, Blood Glucose, Blood Pressure, California, Cardiovascular Diseases, Fasting, Female, Glucose Tolerance Test, Heart Diseases, Glycated Hemoglobin, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Predictive Value of Tests, Reference Values, Risk Factors, Sex Characteristics, Triglycerides, Biomarkers, Body Mass Index, Myocardial Ischemia, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review